Skip to main content
Sinopharm Group Co. Ltd. logo

Sinopharm Group Co. Ltd. — Investor Relations & Filings

Ticker · 1099 ISIN · CNE100000FN7 LEI · 529900N54X78YH9JYK92 HKEX Wholesale and retail trade
Open in API
Filings indexed 1,603 across all filing types
Latest filing 2025-01-20 Proxy Solicitation & In…
Country CN China
Listing HKEX 1099

About Sinopharm Group Co. Ltd.

http://www.sinopharmholding.com

Sinopharm Group Co. Ltd. is a major state-owned enterprise recognized as the largest pharmaceutical logistics provider in Asia and a leading distributor and retailer of healthcare products. The company's core business revolves around providing comprehensive medical supply chain services, encompassing the wholesale and retail distribution of pharmaceuticals, medical devices, and general healthcare products. Sinopharm serves a broad customer base, including hospitals, primary health service institutions, and retail pharmacies. Furthermore, the Group maintains an integrated ecosystem that extends beyond distribution into the manufacturing of pharmaceuticals and chemical reagents, medical services, and industry-finance integration, positioning it as a full-spectrum service provider in the healthcare sector.

Recent filings

Filing Released Lang Actions
FORM OF PROXY FOR EXTRAORDINARY GENERAL MEETING TO BE HELD ON WEDNESDAY, 12 FEBRUARY 2025
Proxy Solicitation & Information Statement Classification · 99% confidence The document is a FORM OF PROXY for an Extraordinary General Meeting, providing shareholders with the ballot form and instructions to appoint proxies and vote on board appointments at the EGM. This is clearly a proxy solicitation document sent to shareholders in connection with a meeting. Therefore, it falls under Proxy Solicitation & Information Statement (PSI).
2025-01-20 English
NOTICE OF EXTRAORDINARY GENERAL MEETING
Regulatory Filings Classification · 75% confidence The document is the official notice of an Extraordinary General Meeting (EGM), announcing the meeting date, location, agenda (board director appointments), and proxy details. It is a regulatory announcement filed with the Hong Kong Stock Exchange rather than the text of an AGM presentation, annual or interim report, proxy statement in the U.S.-style, or voting results. There is no detailed proxy solicitation booklet (PSI) or comprehensive materials beyond the meeting notice, so it falls under the general “Regulatory Filings” category.
2025-01-20 English
(1) PROPOSED APPOINTMENT OF DIRECTORS&#x3b; AND (2) NOTICE OF EGM
Proxy Solicitation & Information Statement Classification · 92% confidence The document is a comprehensive shareholder circular providing detailed information on the proposed appointment of directors and convening an extraordinary general meeting (EGM), including a letter from the board, biographies of director nominees, proxy form instructions, and the formal notice of meeting. This mirrors a proxy solicitation/information statement rather than a simple report announcement or a post‐meeting voting result. It is not an annual or quarterly report, earnings release, or director dealing notice, but a solicitation of votes for a board election – fitting the Proxy Solicitation & Information Statement category.
2025-01-20 English
INSIDE INFORMATION ANNOUNCEMENT RESULTS ESTIMATE OF SINOPHARM ACCORD FOR THE YEAR OF 2024
Earnings Release Classification · 90% confidence The document is a standalone announcement under HKEx Rules disclosing a preliminary 2024 full‐year profit estimate (“net profit attributable… Profit: 561–760 million”) with key highlights and reasons for changes, made pursuant to listing rules. It is not the full audited Annual Report (10‐K) nor a mere publication notice (RPA). This type of initial earnings announcement fits the Earnings Release category. FY 2024
2025-01-19 English
List of Directors and Their Role and Function
Governance Information Classification · 75% confidence The document is a Hong Kong stock exchange announcement titled “List of Directors and Their Role and Function,” providing the current board composition and committee memberships. It does not contain financial results or voting outcomes, nor does it announce any change of personnel. Instead, it describes the company’s board structure and governance framework. This aligns with a Governance Information filing (CGR).
2025-01-08 English
ANNOUNCEMENT CHANGE OF DIRECTORS
Board/Management Information Classification · 95% confidence The document is an announcement regarding the proposed appointment and resignation of company directors, with detailed biographies and board approvals. It clearly pertains to changes in the board of directors, matching the definition for Board/Management Information.
2025-01-08 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.